<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several genetic mechanisms have been shown to diversity the expressed antibody repertoire of committed B lymphocytes </plain></SENT>
<SENT sid="1" pm="."><plain>These include somatic hypermutation, V gene replacement, and ongoing gene rearrangement </plain></SENT>
<SENT sid="2" pm="."><plain>These mechanisms may be operational at discrete points in the B-cell differentiation pathway and may generate idiotypic diversity in various malignant B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Hypermutation of the Ig variable region has been shown to occur in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, but not in <z:hpo ids='HP_0004812'>pre-B cell acute lymphoblastic leukemia</z:hpo>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, or <z:mp ids='MP_0009440'>myeloma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>To study hypermutation in a large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, we use a polymerase chain reaction-based approach, employing consensus VH and JH primers, to clone and sequence rearranged Ig heavy chain variable regions </plain></SENT>
<SENT sid="5" pm="."><plain>Neither <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells immortalized in rescue fusions nor idiotypic variants of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-derived cell line generated through ongoing lambda light chain gene rearrangements show any significant number of variable region mutations </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, at the in vivo stage of B-cell differentiation from which this large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> arose, Ig variable region hypermutation was not occurring, nor did it occur during propagation in vitro of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, the window of hypermutation in malignant B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> is more precisely defined, which may have clinical implications for diagnostic and therapeutic approaches directed at the Ig variable region </plain></SENT>
</text></document>